封面
市场调查报告书
商品编码
1672995

癌症治疗市场:依治疗类型、癌症类型和地区划分

Cancer Therapy Market, By Therapy Type, By Cancer Type, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 174 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球癌症治疗市场规模估计为 2,309.6 亿美元,预计到 2032 年将达到 5,303.7 亿美元,2025 年至 2032 年的复合年增长率为 12.6%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 2309.6亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025 年至 2032 年复合年增长率 12.60% 2032 年金额预测 5303.7亿美元
数字。 2025 年各地区癌症治疗市场占有率(%)
癌症治疗市场-IMG1

癌症继续对世界范围的医学造成重大挑战。许多国家人口快速老化导致癌症发生率上升。此外,环境污染加剧和生活方式的改变,如不健康的饮食、缺乏运动、吸烟和饮酒,也会增加人们罹患癌症的风险。儘管治疗性介入取得了进展,但癌症死亡率仍然很高。因此,最近的肿瘤学药物开发活动集中在改善患者的治疗效果和生活品质。

市场动态

癌症治疗市场受到多种因素的推动,例如由于生活方式的改变导致全球癌症发病率增加、人口老龄化加剧、标靶治疗和个性化医疗的采用日益增多、新兴国家医疗基础设施的扩大以及製药公司对肿瘤学研发的投资增加。然而,癌症治疗的高昂费用阻碍了其广泛应用。此外,核准核准週期较长也在一定程度上对市场成长带来挑战。另一方面,强大的癌症临床测试管道和生物相似药的进入为预测期内的市场扩张提供了巨大的机会。

研究的主要特点

  • 本报告对全球癌症治疗市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模(十亿美元)和年复合成长率(CAGR%)。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 全球癌症治疗市场的主要企业已根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行了分析。
  • 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球癌症治疗市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过全球癌症治疗市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 收购和合作场景
  • 赎回情况
  • 流行病学
  • 治疗流程(病人历程)
  • 癌症诊断和治疗方案
  • 管道分析
  • 患者权益倡导与赋权
  • 监管情景
  • 定价分析
  • PEST分析
  • 波特分析

第四章 全球癌症治疗市场-冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球癌症治疗市场(按治疗类型划分)(十亿美元)

  • 介绍
  • 化疗
  • 烷化剂
  • 抗代谢物
  • 抗肿瘤抗生素
  • 其他的
  • 标靶治疗
  • 单株抗体
  • 小分子抑制剂
  • 其他的
  • 免疫疗法
  • 免疫查核点抑制剂
  • 溶瘤病毒治疗
  • T细胞治疗
  • 放射治疗
  • 其他的

6. 2020 年至 2032 年全球癌症治疗市场(按癌症类型划分)(十亿美元)

  • 介绍
  • 乳癌
  • 肺癌
  • 大肠直肠癌
  • 摄护腺癌
  • 血癌
  • 肝癌
  • 甲状腺癌
  • 头颈癌
  • 皮肤癌
  • 其他的

7. 2020 年至 2032 年全球癌症治疗市场(按地区划分)(十亿美元)

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第八章 竞争格局

  • 公司简介
    • Bristol-Myers Squibb Company
    • AstraZeneca
    • Pfizer Inc.
    • Novartis AG
    • GSK plc.
    • Sanofi
    • Bayer AG
    • Amgen Inc.
    • Gilead Sciences, Inc.
    • Boehringer Ingelheim International GmbH
    • ADC Therapeutics SA
    • F. Hoffmann-La Roche Ltd
    • Merck & Co., Inc.
    • Eureka Therapeutics, Inc.
    • AbbVie Inc.
    • Fate Therapeutics
    • Sorrento Therapeutics, Inc.
    • Carrick Therapeutics Limited
    • Atara BIoTherapeutics, Inc.
    • Celluris
    • NeoTX
    • Kazia Therapeutics Limited

第 9 章 分析师观点

  • 兴衰
  • 一致的机会地图

第十章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI5335

Global Cancer Therapy Market is estimated to be valued at USD 230.96 Bn in 2025 and is expected to reach USD 530.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 230.96 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.60% 2032 Value Projection: USD 530.37 Bn
Figure. Cancer Therapy Market Share (%), By Region 2025
Cancer Therapy Market - IMG1

Cancer continues to pose significant healthcare challenges worldwide. Rapidly aging population profiles in numerous countries have contributed to the rising cancer prevalence. Furthermore, increasing environmental pollution levels and lifestyle changes such as unhealthy diets, lack of physical activity, tobacco use, and alcohol consumption have elevated the cancer risk in populations. Despite advancements in therapeutic interventions, cancer mortality remains substantial. As a result, drug development activity in the oncology sector has intensified in recent times focused on improving patient outcomes and quality of life.

Market Dynamics:

The cancer therapy market is driven by various factors such as the increasing prevalence of cancer worldwide owing to changing lifestyle patterns, growing geriatric population, increasing adoption of targeted therapies and personalized medicine, expansion of healthcare infrastructure across emerging nations, and rising investment in cancer R&D by pharmaceutical companies. However, high treatment costs associated with cancer care pose limitations to widespread adoption. Moreover, long regulatory approval timelines for new drug approvals also challenge market growth to some extent. Meanwhile, robust cancer clinical trial pipelines and the entry of biosimilars provide significant opportunities for market expansion over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global cancer therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cancer therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Bayer AG, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., ADC Therapeutics SA, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Eureka Therapeutics, Inc., AbbVie Inc., Fate Therapeutics, Sorrento Therapeutics, Inc., Carrick Therapeutics Limited, Atara Biotherapeutics, Inc., Celluris, NeoTX, and Kazia Therapeutics Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cancer therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapy market.

Detailed Segmentation-

  • Therapy Type:
    • Chemotherapy
    • Alkylating agents
    • Antimetabolites
    • Anti-tumor antibiotics
    • Others
    • Target Therapy
    • Monoclonal antibodies
    • Small molecule inhibitors
    • Others
    • Immunotherapy
    • Immune Checkpoint Inhibitors
    • Oncolytic virus therapy
    • T-cell therapy
    • Radiotherapy
    • Others
  • Cancer Type:
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Blood Cancer
    • Liver Cancer
    • Thyroid Cancer
    • Head and Neck Cancer
    • Skin Cancer
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • AstraZeneca
    • Pfizer Inc.
    • Novartis AG
    • GSK plc.
    • Sanofi
    • Bayer AG
    • Amgen Inc.
    • Gilead Sciences, Inc.
    • Boehringer Ingelheim International GmbH.
    • ADC Therapeutics SA
    • Hoffmann-La Roche Ltd
    • Merck & Co., Inc.
    • Eureka Therapeutics, Inc.
    • AbbVie Inc.
    • Fate Therapeutics
    • Sorrento Therapeutics, Inc.
    • Carrick Therapeutics Limited
    • Atara Biotherapeutics, Inc.
    • Celluris
    • NeoTX
    • Kazia Therapeutics Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Therapy Type
    • Market Snapshot, By Cancer Type
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Acquisitions and Partnerships Scenario
  • Reimbursement Scenario
  • Epidemiology
  • Treatment Algorithm (Patient Journey)
  • Cancer Diagnosis and Treatment Options
  • Pipeline Analysis
  • Patient Advocacy and Empowerment
  • Regulatory Scenario
  • Pricing Analysis
  • PEST Analysis
  • PORTER's Analysis

4. Global Cancer Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 impact on the market

5. Global Cancer Therapy Market, By Therapy Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Chemotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Alkylating agents
  • Antimetabolites
  • Anti-tumor antibiotics
  • Others
  • Target Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Monoclonal antibodies
  • Small molecule inhibitors
  • Others
  • Immunotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immune Checkpoint Inhibitors
  • Oncolytic virus therapy
  • T-cell therapy
  • Radiotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cancer Therapy Market, By Cancer Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Breast Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Lung Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Colorectal Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prostate Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Blood Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Liver Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thyroid Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Head and Neck Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Skin Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cancer Therapy Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Bristol-Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GSK plc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sanofi
    • Bayer AG
    • Amgen Inc.
    • Gilead Sciences, Inc.
    • Boehringer Ingelheim International GmbH.
    • ADC Therapeutics SA
    • F. Hoffmann-La Roche Ltd
    • Merck & Co., Inc.
    • Eureka Therapeutics, Inc.
    • AbbVie Inc.
    • Fate Therapeutics
    • Sorrento Therapeutics, Inc.
    • Carrick Therapeutics Limited
    • Atara Biotherapeutics, Inc.
    • Celluris
    • NeoTX
    • Kazia Therapeutics Limited

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact